Healmusz Clotrimazole Cream
NDC Package 85248-060-01
Package Information
Healmusz Clotrimazole (clotrimazole1% miconazole1% clotrimazole) cream is adults and children 12 years and older: ■ use the tip of the cap to break the seal and open the tube ■wash the affected skin with soap andwater and dry completely before applying ■for athlete's foot between the toes:apply to affected skin between and around the toes twice a day for 1 week(morning and night), or once a day for 4 weeks, or as directed by a doctor. This formulation utilizes a cream delivery system. Marketed by Jiangxi Yudexi Pharmaceutical Co., Ltd, this product is identified by NDC 85248-060 and is authorized under FDA application M005.
Identification & Billing
- RxCUI: 2707698 - clotrimazole 1 % / miconazole 1 % Topical Cream
- RxCUI: 2707698 - clotrimazole 10 MG/ML / miconazole 10 MG/ML Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85248 - Jiangxi Yudexi Pharmaceutical Co., Ltd
- 85248-060 - Healmusz Clotrimazole
- 85248-060-01 - 30 g in 1 TUBE
- 85248-060 - Healmusz Clotrimazole
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85248-060-01 identifies a specific commercial package of 30 g in 1 tube of Healmusz Clotrimazole, a human over the counter drug labeled by Jiangxi Yudexi Pharmaceutical Co., Ltd. This cream is formulated for topical use and contains clotrimazole; miconazole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Jiangxi Yudexi Pharmaceutical Co., Ltd on February 07, 2026. The current certification is valid through December 31, 2027.
How is this Jiangxi Yudexi Pharmaceutical Co., Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85248006001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.